Mylan Pharmaceuticals Inc. recalls Mirtazapine Tablets, USP 45 mg, a) 30 count, b) 100 count and c) 500 count bottles, Rx only, Mylan Pharmaceuticals Inc.…
- Recall date
- January 19, 2017
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0492-2017
- FDA classification
- Class II
- Brand / firm
- Mylan Pharmaceuticals Inc.
- Sold / distributed
- Nationwide
Why it was recalled
Presence of Foreign Tablets/Capsules; possibility of Glipizide 10 mg tablet in bottle
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Mirtazapine Tablets, USP 45 mg, a) 30 count, b) 100 count and c) 500 count bottles, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV
Get recall alerts
Free email alert whenever Mylan Pharmaceuticals Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Mylan Pharmaceuticals Inc.